Literature DB >> 31158434

Regulation of Synaptosomal GLT-1 and GLAST during Epileptogenesis.

Allison R Peterson1, Devin K Binder2.   

Abstract

Astrocytes regulate extracellular glutamate homeostasis in the central nervous system through the Na+-dependent glutamate transporters glutamate transporter-1 (GLT-1) and glutamate aspartate transporter (GLAST). Impaired astrocyte glutamate uptake could contribute to the development of epilepsy but the regulation of glutamate transporters in epilepsy is not well understood. In this study, we investigate the expression of GLT-1 and GLAST in the mouse intrahippocampal kainic acid (IHKA) model of temporal lobe epilepsy (TLE). We used immunohistochemistry, synaptosomal fractionation and Western blot analysis at 1, 3, 7 and 30 days post-IHKA induced status epilepticus (SE) to examine changes in GLT-1 and GLAST immunoreactivity and synaptosomal expression during the development of epilepsy. We found a significant upregulation in GLT-1 immunoreactivity at 1 and 3 days post-IHKA in the ipsilateral dorsal hippocampus. However, GLT-1 immunoreactivity and synaptosomal protein levels were significantly downregulated at 7 days post-IHKA in the ipsilateral hippocampus, a time point corresponding to the onset of spontaneous seizures in this model. GLAST immunoreactivity was increased in specific layers at 1 and 3 days post-IHKA in the ipsilateral hippocampus. GLAST synaptosomal protein levels were significantly elevated at 30 days compared to 7 days post-IHKA in the ipsilateral hippocampus. Our findings suggest that astrocytic glutamate transporter dysregulation could contribute to the development of epilepsy.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  GLT-1; astrocyte; epilepsy; glutamate transporter-1; kainic acid; seizure

Mesh:

Substances:

Year:  2019        PMID: 31158434     DOI: 10.1016/j.neuroscience.2019.05.048

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

Review 1.  The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders.

Authors:  Sahar Alijanpour; Mohammad Miryounesi; Soudeh Ghafouri-Fard
Journal:  Metab Brain Dis       Date:  2022-09-29       Impact factor: 3.655

2.  Mechanisms Underlying Aquaporin-4 Subcellular Mislocalization in Epilepsy.

Authors:  Jenny I Szu; Devin K Binder
Journal:  Front Cell Neurosci       Date:  2022-06-06       Impact factor: 6.147

3.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

4.  Astrocytes and Epilepsy.

Authors:  Devin K Binder; Christian Steinhäuser
Journal:  Neurochem Res       Date:  2021-03-04       Impact factor: 3.996

Review 5.  Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.

Authors:  Jennifer Leigh Green; Wagner Ferreira Dos Santos; Andréia Cristina Karklin Fontana
Journal:  Biochem Pharmacol       Date:  2021-09-24       Impact factor: 5.858

6.  Title: Oops!...Glutamate Did it Again.

Authors:  Jacqueline P Garcia; Chris G Dulla
Journal:  Epilepsy Curr       Date:  2021-10-30       Impact factor: 7.500

Review 7.  The Interconnected Mechanisms of Oxidative Stress and Neuroinflammation in Epilepsy.

Authors:  Anna L M Parsons; Eboni M V Bucknor; Enrico Castroflorio; Tânia R Soares; Peter L Oliver; Daniel Rial
Journal:  Antioxidants (Basel)       Date:  2022-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.